Form 4: CoreWeave CDO Sells Shares Under 10b5-1 Plan
Insider Trading Report
CoreWeave's Chief Development Officer, Brannin McBee, reported sales of Class A Common Stock totaling 22,586 shares through pre-arranged 10b5-1 trading plans.
Summary
- Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported transactions involving Class A and Class B Common Stock on March 23, 2026.
- Transactions included the conversion of 22,915 shares of Class B Common Stock into Class A Common Stock (16,665 shares for Canis Major 2025 GRAT and 6,250 shares for Canis Minor 2025 GRAT).
- A total of 22,586 shares of Class A Common Stock were sold across multiple transactions from two grantor retained annuity trusts (Canis Major 2025 GRAT and Canis Minor 2025 GRAT).
- Sales from Canis Major 2025 GRAT totaled 16,665 shares at weighted average prices ranging from $81.0557 to $84.7346.
- Sales from Canis Minor 2025 GRAT totaled 5,997 shares at weighted average prices ranging from $81.0556 to $84.7347.
- All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted on November 17, 2025.
- Following these transactions, the Canis Major 2025 GRAT and Canis Minor 2025 GRAT each hold 0 shares of Class A Common Stock.
- McBee continues to indirectly hold significant Class B Common Stock through various trusts, including 4,033,902 shares via Canis Major 2025 GRAT (after transfers to 2026 GRAT) and 604,955 shares via Canis Minor 2025 GRAT (after transfers to 2026 GRAT).
- Additional indirect holdings include 54,000 Class A shares via Canis Major SM Trust and 1,800 Class A shares via a child, as well as Class B shares through other family trusts.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While insider selling can sometimes be a concern, the execution under a pre-established 10b5-1 plan mitigates negative interpretations, indicating planned diversification rather than a reaction to adverse company news.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and systematic approach to liquidity rather than an immediate reaction to market conditions.
- Conversions of Class B to Class A Common Stock increase the liquidity of the shares being sold.
Negatives
- The sale of 22,586 shares by a Chief Development Officer represents a reduction in direct beneficial ownership, which some investors might interpret as a lack of confidence, despite the 10b5-1 plan.
Risks
- No specific risks are mentioned in this Form 4 filing beyond the inherent risks associated with insider stock sales, which can sometimes be perceived negatively by the market.
Future Outlook
NA
Management Comments
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.
Industry Context
StockSavvy.ai notes that insider sales executed under a pre-arranged 10b5-1 plan are a common practice for executives to manage personal finances and diversify holdings without signaling a change in company outlook. This is a standard mechanism across various industries for executives to liquidate shares in a compliant and transparent manner.
Comparison to Industry Standards
- NA
Related Party Transactions
- Transactions involve grantor retained annuity trusts (Canis Major 2025 GRAT and Canis Minor 2025 GRAT) where the reporting person or their spouse is the trustee and/or beneficiary.
- Indirect holdings are reported through other family trusts (Canis Major SM Trust, Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC, Canis Major 2026 GRAT, Canis Minor 2026 GRAT) where the reporting person or spouse serves as manager or has control over the trustee.
Stakeholder Impact
- Shareholders: The sale of shares by a key executive could be perceived as a minor negative, but the 10b5-1 plan context generally reduces this concern. It provides transparency regarding executive stock transactions.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2025-11-17 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2026-03-23 | Date of reported stock transactions (conversions and sales). |
| 2026-03-25 | Date the Form 4 was signed and filed. |
Keywords
CoreWeave, CRWV, Brannin McBee, insider trading, Form 4, stock sale, 10b5-1 plan, beneficial ownership, Class A Common Stock, Class B Common Stock, grantor retained annuity trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.